Drug Discovery World

MAY 6, 2024

In Paris itself, Institut Curie is a major cancer hospital, from which One Biosciences was spun-off. In January 2024, he was one of 10 recipients to receive a 2024 European Molecular Biology Organisation (EMBO) Laboratory Installation Grant to support his work developing reliable and predictable gene editing tools.

Drugs 147

Drugs Science Molecular Biology Clinical Trials 147

Broad Institute

AUGUST 7, 2023

Now, a team of MIT, Massachusetts General Hospital (MGH), Broad Institute of MIT and Harvard, and Harvard Medical School (HMS) researchers has discovered how STING activates those two pathways. Paper Cited Liu B, Carlson R, et al. Human STING is a proton channel. Online August 3, 2023.

Regulations 91

Regulations Engineering Clinical Trials DNA 91

The Pharma Data

SEPTEMBER 17, 2020

The Elecsys Anti-SARS-CoV-2 serology test can be used to quantitatively measure antibodies in people who have been exposed to the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and can play an important part in characterising a vaccine-induced immune response. The molecular biology of coronaviruses.

Vaccine 52

Vaccine Virus Clinical Trials Immune Response 52

LifeSciVC

JULY 1, 2024

The central dogma of molecular biology is that information generally (with few exceptions) flows from DNA to RNA to Protein. Build your social immunity. The adaptive immune response identifies and responds to highly specific antigens associated with infections and cancer. Remember life’s Central Dogma.

Science 84

Science Immune Response Molecular Biology RNA 84

Codon

JULY 27, 2023

in Current Biology. There’s a TV show where a bunch of doctors are walking through a hospital corridor. ” Wellcome Collection , London I wrapped up my series on “30 Days of Great Biology Papers.” In response, the U.S. a lower risk of immune responses. From McKyton et al.

Therapies 52

Therapies RNA DNA Engineering 52

Codon

JULY 27, 2023

in Current Biology. There’s a TV show where a bunch of doctors are walking through a hospital corridor. ” Wellcome Collection , London I wrapped up my series on “30 Days of Great Biology Papers.” In response, the U.S. a lower risk of immune responses. From McKyton et al.

Therapies 52

Therapies RNA DNA Engineering 52

Codon

FEBRUARY 13, 2024

Regulators traditionally want to see a single, stable, well-characterized drug before giving the green light for it to be tested in a clinical trial, not dozens of different viruses; let alone ones that are best found in unappealing places like sewage , hospital waste, or bird poop. 4 But the same barriers still exist today.

Therapies 118

Therapies Virus DNA Clinical Trials 118